Clinical outcomes of 30 cases (1997-2004) of canine gastrointestinal lymphoma.
In 30 cases of canine gastrointestinal lymphoma, each case was localized to the stomach, small intestine, large intestine, or two or more sites. Treatments consisted of surgery alone (n=4), surgery with chemotherapy (n=8), chemotherapy alone (n=15), or supportive care (n=3). Four dogs died, 24 were euthanized, and two are currently alive. Median survival time for all cases was 13 days. In both surviving dogs, the site of lymphoma was the large intestine. Canine gastrointestinal lymphoma is a severe disease that warrants a poor to grave prognosis. However, cases of colorectal origin may have longer survival times.
Frank
Joseph David
JD
Department of Small Animal Clinical Sciences, Veterinary Medical Center, Michigan State University, East Lansing, Michigan 48824-1314, USA.
Reimer
S Brent
SB
Kass
Philip H
PH
Kiupel
Matti
M
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004283:Dog Diseases / Q000188:drug therapy* / Q000601:surgery*; D004285:Dogs; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000662:veterinary*; D008223:Lymphoma / Q000188:drug therapy / Q000601:surgery / Q000662:veterinary*; D008297:Male; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome
D000970:Antineoplastic Agents